A novel Bim-BH3-derived Bcl-XL inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity (Cell Cycle 7, 20 (3211-3224))

Raffaella Ponassi, Barbara Biasotti, Valeria Tomati, Silvia Bruno, Alessandro Poggi, Davide Malacarne, Guido Cimoli, Annalisa Salis, Sarah Pozzi, Maurizio Miglino, Gianluca Damonte, Pietro Cozzini, Francesca Spyrakis, Barbara Campanini, Luca Bagnasco, Nicoletta Castagnino, Lorenzo Tortolina, Anna Mumot, Francesco Frassoni, Antonio DagaMichele Cilli, Federica Piccardi, Ilaria Monfardini, Miriam Perugini, Gabriele Zoppoli, Cristina D'Arrigo, Raffaele Pesenti, Silvio Parodi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)3703
Number of pages1
JournalCell Cycle
Volume11
Issue number19
DOIs
Publication statusPublished - Oct 1 2012

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

Ponassi, R., Biasotti, B., Tomati, V., Bruno, S., Poggi, A., Malacarne, D., Cimoli, G., Salis, A., Pozzi, S., Miglino, M., Damonte, G., Cozzini, P., Spyrakis, F., Campanini, B., Bagnasco, L., Castagnino, N., Tortolina, L., Mumot, A., Frassoni, F., ... Parodi, S. (2012). A novel Bim-BH3-derived Bcl-XL inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity (Cell Cycle 7, 20 (3211-3224)). Cell Cycle, 11(19), 3703. https://doi.org/10.4161/cc.7.20.6830